Shopping Cart   Contact Us   Home

  To view the report in PDF format, you first need to download the free Adobe Acrobat Viewer. The Acrobat Viewer will launch the file so that you can see the document on your monitor and then print it. Download Adobe Acrobat.

Download the ReportPremium Resource

 
Find a wealth of reports, white papers and other behavioral health and social service resources in the 
OPEN MINDS
Industry Resources Library.

 

September 2002

Department of Health and Human Services, Office of Inspector General

ShareDraft OIG Compliance Program For Pharmaceutical Manufacturers

The federal Department of Health and Human Services Office of Inspector General (OIG) released a draft compliance program for pharmaceutical manufacturers on September 30, 2002, stating that many of the practices commonly used in the marketing and sale of prescription drugs could be in violation of federal fraud and abuse laws. Issued as a guidance to the pharmaceutical industry, the new standards specifically state that drug makers can not offer incentive payments or other "tangible benefits" to encourage or reward the prescribing or purchase of particular drugs by doctors, health plans or companies that manage drug benefits for employers and insurers.

Premium Membership Required

 


Shopping Cart | Contact Us | Home

OPEN MINDS